— Know what they know.
Not Investment Advice

ACUS OTC

Acusphere, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: +0.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 48 · $49 mcap · 5M float · 0.0021% daily turnover

Cash Flow Trends

Operating Cash Flow
-$42M +13.3% ▲
Capital Expenditures
$996K +8.6% ▲
5Y CAGR: +7.7%
Free Cash Flow
-$43M +13.2% ▲
Dividends Paid
$2M +4.5% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$34M -489.5% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2003FY2004FY2005FY2006FY2007
— Operating Activities —
Net Income-$22M-$30M-$45M-$61M-$54M
Depreciation & Amort.$2M$1M$4M$10M$8M
Stock-Based Comp.$0$0$0$0$0
Change in Working Capital$2M$10M$6M-$208K-$2M
Other Non-Cash Items$2M-$322K$4M$3M$6M
Operating Cash Flow-$16M-$19M-$31M-$48M-$42M
— Investing Activities —
Capital Expenditures-$535K-$12M-$33M-$1M-$996K
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$195K$0$0$0$0
Other Investing-$119K-$258K$112K-$130K$3K
Investing Cash Flow-$459K-$12M-$33M-$1M-$993K
— Financing Activities —
Net Debt Issuance$15M$2M$12M-$1M-$8M
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0-$2M-$2M-$2M
Other Financing$0$366$0$0$0
Financing Cash Flow$63M$22M$69M$58M$9M
Net Change in Cash$47M-$9M$6M$9M-$34M
Cash End of Period$55M$45M$51M$60M$26M
Free Cash Flow-$16M-$32M-$64M-$49M-$43M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms